Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Shamrock Medicaments (India) Limited, is an unlisted public company incorporated on 30 August, 2001. It is classified as a public limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 10.00 lac and the total paid-up capital is INR 5.00 lac.
The current status of Shamrock Medicaments (India) Limited is - Active.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 1
Total Amount : 0.3 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Sangini K Khokhani
Shareholder
|
00321998 | 18 years |
Director | Kalpesh Rameshchandra Khokhani
Shareholder
|
00322052 | 6 years |
Director | Jitesh Rameshchandra Khokhani
Shareholder
|
00611815 | 18 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SHAMROCK INFOSYS LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
DUKANSH TRADING PRIVATE LIMITED |
Strike Off
|
4.5 Cr | 1 | Maharashtra |
SHAMROCK FINLEASE LIMITED |
Active
|
1.0 Cr | 2 | Maharashtra |
SHAMROCK INDUSTRIAL COMPANY LIMITED |
Active
|
5.4 Cr | 2 | Maharashtra |
SHAMROCK ADVERTISING AND PUBLISHING COMPANY PVT LTD |
Active
|
30.0 L | 2 | Maharashtra |
SHIRAAJ PHARMACHEMI PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
YSK LABORATORIES PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Maharashtra |
PENEM PHARMACHEMI PRIVATE LIMITED |
Active
|
2.0 L | 1 | Maharashtra |
RAAJSHI INVECORP LLP |
Active
|
1.0 L | 1 | Maharashtra |
SHAMROCK STERIOTECH LLP |
Active
|
1.0 L | 1 | Maharashtra |
SHIRAJ INVECORP LLP |
Active
|
1.0 L | 1 | Maharashtra |
SHAMROCK PHARMA LLP |
Active
|
5.0 L | 1 | Maharashtra |
SHAMROCK NUTRASCIENCES LLP |
Converted and Dissolved
|
7.0 L | 1 | Maharashtra |
SHAMROCK INVECORP LLP |
Active
|
7.0 L | 1 | Maharashtra |
SHAMROCK FERMENTECH LLP |
Active
|
7.0 L | 1 | Maharashtra |
CREST CONCEPTS LLP |
Active
|
1.0 L | 1 | Maharashtra |
SHAMROCK INTERNATIONAL LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
UNIMARK REMEDIES LIMITED |
Active
|
10.0 Cr | 1 | Maharashtra |
The incorporation date of SHAMROCK MEDICAMENTS (INDIA) LIMITED is 30 August, 2001
The authorized share capital of SHAMROCK MEDICAMENTS (INDIA) LIMITED is INR ₹ 10.0 L.
The paid-up capital of SHAMROCK MEDICAMENTS (INDIA) LIMITED is INR ₹ 5.0 L.
The registered address of SHAMROCK MEDICAMENTS (INDIA) LIMITED is 83 E, HANSRAJ PRAGJI BUILDING,OFF Dr. E MOSES ROAD Dr. E MOSES ROAD, WORLI MUMBAI Mumbai City Maharashtra - 400018
The CIN number of SHAMROCK MEDICAMENTS (INDIA) LIMITED is U51397MH2001PLC133209.